Developing Ex Vivo Models in Breast and Lung Cancer
An ACED Research Project Exemplar
Developing Ex Vivo Models in Breast and Lung Cancers
Prof Sarah Cartmell, Prof Alberto Saiani, Dr Andrew Gilmore
Project Summary
This infrastructure award is focusing on developing our ability to develop human-derived models representing at risk normal tissue or early malignant lesions for study cancers such as breast and lung cancer. These models will explore the process of cancer initiation and open up new mechanisms for identifying the earliest stages of cancer transformation and biomarkers. This capacity once tested will provide a testbed with which can be used for research models of other cancers ex vivo.
Navigation
Research Themes
Navigate back to read about the other Research Themes and projects
About ACED Manchester
ACED is a £55 million partnership between world-leading early detection institutes and organisations dedicated to improving the early detection of cancer.
Funding Opportunities
Discover the opportunities for ACED Member organisations to lever additional ACED funding in strategic areas.